Back to Search Start Over

Impact of Lung Function and Exacerbations on Health-Related Quality of Life in COPD Patients Within One Year: Real-World Analysis Based on Claims Data

Authors :
Stöber,Alisa
Lutter,Johanna I
Schwarzkopf,Larissa
Kirsch,Florian
Schramm,Anja
Vogelmeier,Claus F
Leidl,Reiner
Stöber,Alisa
Lutter,Johanna I
Schwarzkopf,Larissa
Kirsch,Florian
Schramm,Anja
Vogelmeier,Claus F
Leidl,Reiner
Publication Year :
2021

Abstract

Alisa Stöber,1,2 Johanna I Lutter,1,3 Larissa Schwarzkopf,1,3,4 Florian Kirsch,1 Anja Schramm,5 Claus F Vogelmeier,6 Reiner Leidl1,7 1Institute of Health Economics and Health Care Management, Helmholtz Zentrum München, Neuherberg, Germany; 2Institute for Medical Information Processing, Biometry, and Epidemiology (IBE), Ludwig-Maximilians-University Munich (LMU), Munich, Germany; 3Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL), Munich, Germany; 4Institute fuer Therapieforschung (IFT), Working Group Therapy and Health Services Research, Munich, Germany; 5AOK Bayern, Service Center of Health Care Management, Regensburg, Germany; 6Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-University Marburg, Member of the German Center for Lung Research (DZL), Marburg, Germany; 7Munich Center of Health Sciences (MC-Health), Institute for Health Economics and Management, Ludwig-Maximilians-University Munich (LMU), Munich, GermanyCorrespondence: Alisa StöberInstitute of Health Economics and Health Care Management, Helmholtz Zentrum München, Neuherberg, 85764, GermanyTel +49 89 3187/43572Email alisa.stoeber@helmholtz-muenchen.dePurpose: Real-world evidence on the impact of forced expiratory volume in one second (FEV1) and exacerbations on health-related quality of life (HRQoL) in patients with chronic obstructive pulmonary disease (COPD) is sparse especially with regard to GOLD ABCD groups. This study investigates how changes in FEV1 and exacerbations affect generic and disease-specific HRQoL in COPD patients over one year.Methods: Using German claims data and survey data, we classified 3016 COPD patients and analyzed their health status by GOLD groups AB and CD. HRQoL was measured with the disease-specific COPD assessment test (CAT) and the visual analog scale (VAS) from the generic Euro-Qol 5D-5L. We applied change score models to assess associations betwee

Details

Database :
OAIster
Notes :
text/html, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1286360674
Document Type :
Electronic Resource